Evidence map›Paper›PMID 35200280›Full record

ArticleBehavioral sciences (Basel, Switzerland)2022

Investigating the Role of Insight, Decision-Making and Mentalizing in Functional Outcome in Schizophrenia: A Cross-Sectional Study.

Paula Jhoana Escobedo-Aedo, Ana Forjan-González, Adela Sánchez-Escribano Martínez, Verónica González Ruiz-Ruano, Sergio Sánchez-Alonso, Laura Mata-Iturralde, Laura Muñoz-Lorenzo, Enrique Baca-García, Anthony S David, Javier-David Lopez-Morinigo

Open access · goldAbstract read
In one paragraph

Article in Behavioral sciences (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Evaluation of the Relationship between Disability and Disease Severity, Cognitive Functions, and Insight in Patients with Schizophrenia.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2024
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Paula Jhoana Escobedo-AedoDepartamento de Psiquiatría, IIS-Fundación Jiménez Díaz, 28040 Madrid, Spain.ORCID 0000-0003-2579-7370
Ana Forjan-GonzálezDepartamento de Psiquiatría, IIS-Fundación Jiménez Díaz, 28040 Madrid, Spain.
Adela Sánchez-Escribano MartínezDepartamento de Psiquiatría, IIS-Fundación Jiménez Díaz, 28040 Madrid, Spain.
Verónica González Ruiz-RuanoDepartamento de Psiquiatría, IIS-Fundación Jiménez Díaz, 28040 Madrid, Spain.ORCID 0000-0002-8346-3259
Sergio Sánchez-AlonsoDepartamento de Psiquiatría, IIS-Fundación Jiménez Díaz, 28040 Madrid, Spain.
Laura Mata-IturraldeDepartamento de Psiquiatría, IIS-Fundación Jiménez Díaz, 28040 Madrid, Spain.
Laura Muñoz-LorenzoDepartamento de Psiquiatría, IIS-Fundación Jiménez Díaz, 28040 Madrid, Spain.
Enrique Baca-GarcíaDepartamento de Psiquiatría, IIS-Fundación Jiménez Díaz, 28040 Madrid, Spain.ORCID 0000-0002-6963-6555
Anthony S DavidDivision of Psychiatry, Faculty of Brain Sciences, Institute of Mental Health, University College London, London WC1E 6BT, UK.
Javier-David Lopez-MorinigoDepartamento de Psiquiatría, IIS-Fundación Jiménez Díaz, 28040 Madrid, Spain.
Hospital Universitario Fundación Jiménez Díaz · ESCatholic University of the Maule · CLHospital General Universitario Gregorio Marañón · ESInstitute of Mental Health · GB

Funding

Universidad Autónoma de Madrid (Spain) and European Union via the Intertalentum Project Grant-Marie Skłodowska Curie Action GA 713366
6 · The paper itself

Abstract

backgroundRecovery has become a priority in schizophrenia spectrum disorders (SSDs). This study aimed to investigate predictors of objective-general functioning and disability-and subjective-quality of life (QoL)-measures of functional outcomes in SSD.

methodsSample:

resultsYoung age and being employed (R

conclusionsNegative, disorganization and depressive symptoms, older age, unemployment, poor premorbid adjustment, previous suicide attempts and illness awareness appear to underlie a poor global functional outcome in SSD. Achieving recovery in SSD appears to require both symptomatic remission (e.g., through antipsychotics) and measures to improve mastery and relieve low mood.

Indexed as

disabilityfunctioningmetacognitionquality of lifeschizophrenia spectrum disorders

Identifiers

PMID35200280
PMCPMC8868582
OpenAlexW4210755720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.